NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

Neuroimaging Markers of Alzheimer Disease: a Longitudinal Population Study
Neuroimaging Markers of Alzheimer Disease: a Longitudinal Population Study

NCT01582919

CompletedNA

Sponsor: University Hospital, Bordeaux

Conditions: Dementia, Alzheimer Disease

Interventions: Neuroimaging

Countries: France

It is now acknowledged that Alzheimer's disease is characterized by a long period of pathophysiological change. Developing new strategies to achieve diagnoses as early as possible has become a major goal for therapies aimed at slowing the progression of this disease. While diagnoses currently rely principally on clinical neuropsychology, the typical diagnostic criteria of NINCDS-ADRDA are inapplicable in the early stage of the disease. The goal of our project is to identify very early imaging markers for Alzheimer's disease among patients with no report of cognitive difficulties. In order to achieve this goal, we propose a longitudinal study in an elderly population cohort.

Eligibility overview

Sex: ALL

Age: 65 Years to

Healthy volunteers: No

Study type: INTERVENTIONAL

Eligibility criteria
Inclusion Criteria:

* At least 65 years old
* Be retired from agricultural profession
* live in rural area in Gironde (France)

Exclusion Criteria:

* Lefthanded
* having a dementia (MMSE \< 13)
* Having a vascular cerebral accident
* Parkinson disease
* RMI exclusion criteria
* \[18F\]-FDG PET SCAN exclusion criteria
* Poor health condition does not allowing transport to neuroimaging service
Locations (1)
  • Bordeaux, France